
Marsha M. Tsay
Examiner (ID: 332, Phone: (571)272-2938 , Office: P/1656 )
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1656, 1653 |
| Total Applications | 1124 |
| Issued Applications | 471 |
| Pending Applications | 130 |
| Abandoned Applications | 543 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16583167
[patent_doc_number] => 20210017569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => Ligase Screening Assay
[patent_app_type] => utility
[patent_app_number] => 16/981607
[patent_app_country] => US
[patent_app_date] => 2019-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14782
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16981607
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/981607 | Ligase Screening Assay | Mar 17, 2019 | Pending |
Array
(
[id] => 14870561
[patent_doc_number] => 20190285522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => REMOVAL OF SALT FROM AQUEOUS SOLUTIONS FOR METABOLOMICS: TARGETED SALT PRECIPITATION
[patent_app_type] => utility
[patent_app_number] => 16/290053
[patent_app_country] => US
[patent_app_date] => 2019-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10461
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16290053
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/290053 | REMOVAL OF SALT FROM AQUEOUS SOLUTIONS FOR METABOLOMICS: TARGETED SALT PRECIPITATION | Feb 28, 2019 | Abandoned |
Array
(
[id] => 14777987
[patent_doc_number] => 20190263891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => PROCESS FOR ISOLATING BIOACTIVE BIOMOLECULES FROM ANIMAL BY-PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 16/286969
[patent_app_country] => US
[patent_app_date] => 2019-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4680
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16286969
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/286969 | PROCESS FOR ISOLATING BIOACTIVE BIOMOLECULES FROM ANIMAL BY-PRODUCTS | Feb 26, 2019 | Abandoned |
Array
(
[id] => 14712827
[patent_doc_number] => 20190247477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => PREVENTION AND REDUCTION OF BLOOD LOSS
[patent_app_type] => utility
[patent_app_number] => 16/281276
[patent_app_country] => US
[patent_app_date] => 2019-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10412
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16281276
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/281276 | Prevention and reduction of blood loss | Feb 20, 2019 | Issued |
Array
(
[id] => 16541289
[patent_doc_number] => 20200407702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => Botulinum Neurotoxin Biohybrid
[patent_app_type] => utility
[patent_app_number] => 16/975308
[patent_app_country] => US
[patent_app_date] => 2019-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15418
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16975308
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/975308 | Botulinum Neurotoxin Biohybrid | Feb 20, 2019 | Abandoned |
Array
(
[id] => 16726532
[patent_doc_number] => 20210093679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => ENGINEERED GUT MICROBES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/967382
[patent_app_country] => US
[patent_app_date] => 2019-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19968
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16967382
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/967382 | ENGINEERED GUT MICROBES AND USES THEREOF | Feb 3, 2019 | Abandoned |
| 16/266096 | ENZYMATIC AND PEPTIDE BASED IN-CAN PAINT AND COATING PRESERVATIVES | Feb 2, 2019 | Abandoned |
Array
(
[id] => 18329507
[patent_doc_number] => 11634736
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-25
[patent_title] => Methods and materials for the biosynthesis of compounds involved in the tricarboxylic acid cycle and derivatives and compounds related thereto
[patent_app_type] => utility
[patent_app_number] => 16/264781
[patent_app_country] => US
[patent_app_date] => 2019-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12567
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 424
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16264781
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/264781 | Methods and materials for the biosynthesis of compounds involved in the tricarboxylic acid cycle and derivatives and compounds related thereto | Jan 31, 2019 | Issued |
Array
(
[id] => 14653443
[patent_doc_number] => 20190233850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => METHODS AND MATERIALS FOR THE BIOSYNTHESIS OF BETA HYDROXY ACIDS AND DERIVATIVES AND COMPOUNDS RELATED THERETO
[patent_app_type] => utility
[patent_app_number] => 16/264759
[patent_app_country] => US
[patent_app_date] => 2019-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7973
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16264759
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/264759 | METHODS AND MATERIALS FOR THE BIOSYNTHESIS OF BETA HYDROXY ACIDS AND DERIVATIVES AND COMPOUNDS RELATED THERETO | Jan 31, 2019 | Abandoned |
Array
(
[id] => 20201540
[patent_doc_number] => 12404309
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-02
[patent_title] => Host cell for producing a protein of interest
[patent_app_type] => utility
[patent_app_number] => 16/968719
[patent_app_country] => US
[patent_app_date] => 2019-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 5
[patent_no_of_words] => 13832
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16968719
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/968719 | Host cell for producing a protein of interest | Jan 29, 2019 | Issued |
Array
(
[id] => 15708663
[patent_doc_number] => 20200101097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => Compositions and Methods for Topical and Diagnostic and Therapeutic Transport
[patent_app_type] => utility
[patent_app_number] => 16/241885
[patent_app_country] => US
[patent_app_date] => 2019-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22702
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16241885
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/241885 | Compositions and Methods for Topical and Diagnostic and Therapeutic Transport | Jan 6, 2019 | Abandoned |
Array
(
[id] => 18748557
[patent_doc_number] => 11807856
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-07
[patent_title] => Recombinant
[patent_app_type] => utility
[patent_app_number] => 16/237684
[patent_app_country] => US
[patent_app_date] => 2019-01-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5883
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16237684
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/237684 | Recombinant | Dec 31, 2018 | Issued |
Array
(
[id] => 14625179
[patent_doc_number] => 20190225957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => CHIMERIC CLOTTING FACTORS
[patent_app_type] => utility
[patent_app_number] => 16/228144
[patent_app_country] => US
[patent_app_date] => 2018-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45100
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16228144
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/228144 | Chimeric clotting factors | Dec 19, 2018 | Issued |
Array
(
[id] => 16871500
[patent_doc_number] => 20210164967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => OLFACTORY RECEPTOR INVOLVED IN THE PERCEPTION OF MUSK FRAGRANCE AND THE USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/770457
[patent_app_country] => US
[patent_app_date] => 2018-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20518
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16770457
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/770457 | Olfactory receptor involved in the perception of musk fragrance and the use thereof | Dec 4, 2018 | Issued |
Array
(
[id] => 14375693
[patent_doc_number] => 20190161759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-30
[patent_title] => AMPLIFIED PRODUCTION OF MONOCLONAL ANTIBODIES
[patent_app_type] => utility
[patent_app_number] => 16/203148
[patent_app_country] => US
[patent_app_date] => 2018-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9838
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16203148
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/203148 | AMPLIFIED PRODUCTION OF MONOCLONAL ANTIBODIES | Nov 27, 2018 | Abandoned |
Array
(
[id] => 16483971
[patent_doc_number] => 20200377572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => METHOD FOR STABILIZING HEMOGLOBIN-HAPTOGLOBIN COMPLEX AND A PRESERVATION SOLUTION FOR PRESERVING SPECIMENS CONTAINING HEMOGLOBIN
[patent_app_type] => utility
[patent_app_number] => 16/767810
[patent_app_country] => US
[patent_app_date] => 2018-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6101
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16767810
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/767810 | METHOD FOR STABILIZING HEMOGLOBIN-HAPTOGLOBIN COMPLEX AND A PRESERVATION SOLUTION FOR PRESERVING SPECIMENS CONTAINING HEMOGLOBIN | Nov 27, 2018 | Abandoned |
Array
(
[id] => 18667570
[patent_doc_number] => 11774461
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Iron chelator-containing prothrombin time reagent
[patent_app_type] => utility
[patent_app_number] => 16/767623
[patent_app_country] => US
[patent_app_date] => 2018-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 4213
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16767623
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/767623 | Iron chelator-containing prothrombin time reagent | Nov 26, 2018 | Issued |
Array
(
[id] => 16468489
[patent_doc_number] => 20200370026
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => MODIFIED TRANSGLUTAMINASE
[patent_app_type] => utility
[patent_app_number] => 16/763779
[patent_app_country] => US
[patent_app_date] => 2018-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27450
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 5377
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16763779
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/763779 | MODIFIED TRANSGLUTAMINASE | Nov 21, 2018 | Abandoned |
Array
(
[id] => 16513255
[patent_doc_number] => 20200392513
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => A METHOD FOR GENOME EDITING IN A HOST CELL
[patent_app_type] => utility
[patent_app_number] => 16/955255
[patent_app_country] => US
[patent_app_date] => 2018-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12652
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 183
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16955255
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/955255 | A METHOD FOR GENOME EDITING IN A HOST CELL | Nov 19, 2018 | Abandoned |
Array
(
[id] => 16376677
[patent_doc_number] => 20200325519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => BIOMARKER ASSAY FOR USE IN MONITORING AUTISM
[patent_app_type] => utility
[patent_app_number] => 16/761926
[patent_app_country] => US
[patent_app_date] => 2018-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3927
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16761926
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/761926 | BIOMARKER ASSAY FOR USE IN MONITORING AUTISM | Nov 5, 2018 | Abandoned |